To assess the clinical relevance of the METTL1-TXNDC12-c-Myc axis in HNSCC, we performed immunohistochemical analyses on METTL1, TXNDC12 and c-Myc within an in-house HNSCC cohort. This evidence concerns the gene MYC and head and neck squamous cell carcinoma.